Publication:
Progress of research on engineered extracellular vesicles from different sources for disease treatment

Loading...
Thumbnail Image
Date
2025
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Kang Jinhui ; Wen Jun ; Chen Huifang ; Zhu Cui ; Bai Yinshan
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Histología e Histopatología
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-903
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Extracellular vesicles (EVs) are lipid bilayer nanoparticles that encapsulate proteins, lipids, nucleic acids, and small molecules and display low immunogenicity, high stability, and cross-species transmission. By applying engineering technologies, the surface of EVs can be modified and loaded with cargo with therapeutic properties. Thus, engineered EVs can play important roles in preventing and treating various diseases. However, many challenges and uncertainties are faced in the clinical translation of EVs. In this review, we comprehensively analyzed the types of EVs derived from animal cells, plant cells, and microorganisms and summarized their biological properties and potential for engineering modifications. Furthermore, we also explored their therapeutic potential and discussed recent advancements in relevant clinical trials, aiming to provide scientific guidance for future research on the engineering of EVs and precision treatment of clinical diseases
Citation
item.page.embargo